Abstract
Thirty-two dogs affected with transmissible veneral tumour (TVT) were divided into three treatment groups. In group I vincristine sulphate at 0.025 mg/kg body weight, in group II vinblastine sulphate at 0.150 mg/kg body weight, and in group III vinblastine sulphate at 0.100 mg/kg body weight plus methotrexate at 0.35 mg/kg body weight were given intravenously at weekly intervals. Biopsies were performed on days 0, 3, 7 and 14. The tissues were preserved in 10% neutral buffered formalin and processed routinely for haematoxylin and eosin staining. Histopathologically, the untreated TVT was characterized by sheets or bundles of mostly rounded cells having a large, highly basophilic nucleus with a prominent, highly basophilic nucleolus. Both vincristine and vinblastine primarily affected the nuclei of neoplastic cells, causing condensation, karyorrhexis and karyolysis within 3 days of chemotherapy. The regressing tumour mass showed marked infiltration by lymphocytes, lymphoblasts and macrophages by day 7. There was nearly complete regression of the tumour by day 14, as shown by the almost complete loss of neoplastic cells, with fibrous tissue substitution. However, in group III, the changes occurred more slowly and more injections were needed for complete regression. In both groups I and II, 11/12 of the animals responded completely to the chemotherapy within 3 weeks, while in group III, 6/8 of the dogs responded to the treatment by 21–28 days.
Similar content being viewed by others
Abbreviations
- SD:
-
standard deviation
- TVT:
-
transmissible venereal tumour
References
Amber, E.I., Henderson, R.A., Adeyanju, J.B. and Gyang, E.O., 1990. Single drug chemotherapy of canine transmissible veneral tumour with cyclophosphamide, methotrexate or vincristine. Journal of Veterinary Internal Medicine, 4, 144–147
Anilkumar, T.V., Sarraf, C.E. and Allison, M.R., 1992. Significance of apoptosis in oncology. In: Proceedings of the International Symposium on Advances in Animal Cancer Research, Madras, India, 25
Bender, R.A. and Hamel, E., 1991. Vinca alkaloids. Review Chimicaoggi, July–Aug., 9–14
Betamuzi, E.K., 1992. Risk factors associated with canine TVT in Tanzania. Preventive Veterinary Medicine, 13, 13–17.
Brodey, R.S. and Roszel, J.F., 1967. Neoplasm of the canine uterus, vagina and vulva: a clinicopathologic survey of 90 cases. Journal of the American Veterinary Medical Association, 151, 1294–1307
Brown, N.O., Calvert, C. and MacEwan, E.G., 1980. Chemotherapeutic management of transmissible venereal tumours in 30 dogs. Journal of the American Veterinary Medical Association, 176, 983–986
Calvert, C.A., Leifer, C.E. and MacEwan, E.G., 1982. Vincristine for treatment of transmissible venereal tumour in the dog. Journal of the American Veterinary Medical Association, 181, 163–164
Camacho, A.A. and Laus, J.L., 1989. Study on the efficiency of vincristine in the treatment of dogs infected with transmissible venereal tumour. Ars Veterinaria, 3, 37–42
Chandler, J.P. and Yang, T.J., 1981. Canine transmissible venereal sarcoma: distribution of T and B lymphocytes in blood, draining lymph nodes and tumours at different stages of growth. British Journal of Cancer, 44, 514–521
Cockrill, M. and Beasley, J.N., 1975. Ultrastructural characteristics of canine transmissible venereal tumour at various stages of growth and regression. American Journal of Veterinary Research, 36, 677–681
Das, L.L. and Sahay, P.N., 1989. Surgical treatment of canine transmissible venereal tumour — a retrospective study. Indian Veterinary Journal, 66, 255–258
Das, U., Das, A.K., Das, D. and Das, B.B., 1991a. Clinical report of efficiency of chemotherapy in cani transmissible venereal sarcoma. Indian Veterinary Journal, 68, 249–252
Das, A.K., Das, U. and Das, D., 1991b. Clinical report on the efficacy of vincristine on canine transmissible venereal sarcoma. Indian Veterinary Journal, 68, 575–576
Dinesh, N.M., Ranganath, B.N., Jayadevappa, S.M. and Srinivas, C.L., 1993. Gross and microscopic changes in transmissible venereal tumour following vincristine sulphate therapy. Indian Veterinary Journal, 70, 609–611
Gandotra, V.K., Chauhan, F.S. and Sharma, R.D., 1993. Occurrence of canine transmissible venereal tumour and evaluation of two treatments. Indian Veterinary Journal, 70, 854–857
Golden, D.L. and Longston, V.C., 1988. Uses of vincristine and vinblastine in dogs and cats. Journal of the American Veterinary Medical Association, 193, 1114–1117
Hernandez-Jauregui, P., Gonzalez, A.A. and Vega, G.D.L., 1973. Ultrastructural and histochemical pattern of regressing canine venereal lymphoma after cyclophosphamide treatment. Journal of the National Cancer Institute, 51, 1187–1196
Hill, D.L., Yang, J.J. and Watchtel, A., 1984. Canine transmissible venereal sarcoma tumour cells and infiltrating leukocytes, ultrastructure of different growth stages. Veterinary Pathology, 21, 39–45
Horton, R.C., 1990. Methotrexate—an immunomodulator with expanding indications. Journal of Clinical Pharmacology and Therapeutics, 15, 89–95
Idowu, A.L., 1984. A retrospective evaluation of four surgical methods of treating canine transmissible venereal tumour. Journal of Small Animal Practice, 25, 191–198
Karlson, A.G. and Mann, F.C., 1952. The canine transmissible venereal tumour of dogs, observation of forty generations of experimental transfers. Annals of the New York Academy of Sciences, 54, 1197–1213
Luna, L.G., 1968. Manual of Histologic Staining Methods of Armed Forces Institute of Pathology, 3rd edn, (McGraw-Hill, New York)
Osipov, N.E. and Golubeva, V.A., 1976. Diagnosis and treatment of transmissible sarcoma of dogs. Veterinariya (Moscow), 7, 97–98
Otomo, K., Koike, T., Kudo, T. and Sakari, T., 1981. Histological and ultrastructural findings of regressing canine transmissible venereal tumour after repeated transplantation. Japanese Journal of Veterinary Science, 43, 823–832
Padilha, F.J.G., Camacho, A.A., Daleck, C.R. and Ihi, R.A., 1988 Study on the reproductive changes and other side effects following vincristine treatment in dogs. Ars Veterinaria, 4, 25–31
Tuntivonich, P., 1983. Chemotherapeutic treatment of transmissible venereal tumour in dogs. Thai Journal of Veterinary Medicine, 13, 104–121
Wasecki, A. and Mazur, O., 1977. Use of vinblastine in the treatment of stocker's transmissible venereal tumours. Medycyna Weternaryjna, 33, 142–143
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singh, J., Rana, J.S., Sood, N. et al. Clinico-pathological studies on the effect of different anti-neoplastic chemotherapy regimens on transmissible venereal tumours in dogs. Veterinary Research Communications 20, 71–81 (1996). https://doi.org/10.1007/BF00346579
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00346579